Alimera Sciences hopes that its Iluvien ™ insert will be effective against diabetic macular edema. Iluvien™ will release a steroid called fluocinalone acetonide (FA) after insertion into the eye. The Iluvien™ system will deliver the steroid for up to 3 years. It is anticipated that intraocular steroid release may control macular edema and improve vision. The … [Read more...]
Ozurdex Implant Likely to Help Diabetic Macular Edema
There is a new implant available to us in the United States for treatment of macular swelling (edema). The implant, Ozurdex®, is a product of Allergan Pharmaceuticals and received FDA approval in June 2009 for treatment of macular edema caused by retinal vascular occlusions. Ozurdex® is now available for your doctor to use when indicated. What does Ozurdex have … [Read more...]
Steroid Implant May Reduce Diabetic Retinal Edema
In June, the FDA approved a new intraocular device for the treatment of so-called retinal vein occlusions. In this disease, the whole or partial venous tree of the retina becomes occluded. Secondary swelling of the macula occurs thereby reducing vision. Current therapy involves only laser treatment. This new drug delivery system, marketed by Allergan Pharmaceuticals, … [Read more...]
Retinal Vein Occlusions – New Hope on the Horizon
There are two types of retinal vein occlusions (RVO), branch retinal vein occlusions (BRVO) and central retinal vein occlusion (CRVO). In both of these scenarios, the central vein that drains blood from the retina becomes occluded partially (as in the case of BRVO) or completely (as in the case of CRVO). The mainstay of treatment for either has been treatment with an … [Read more...]


